0001209191-21-026826.txt : 20210415 0001209191-21-026826.hdr.sgml : 20210415 20210415161655 ACCESSION NUMBER: 0001209191-21-026826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210413 FILED AS OF DATE: 20210415 DATE AS OF CHANGE: 20210415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Donnell Niall CENTRAL INDEX KEY: 0001780235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40315 FILM NUMBER: 21828676 MAIL ADDRESS: STREET 1: C/O RIVERVEST VENTURE PARTNERS STREET 2: 101 SOUTH HANLEY RD., STE 1850 CITY: ST. LOUIS STATE: MO ZIP: 63105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001637715 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472309515 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 675614 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 BUSINESS PHONE: 619-733-3852 MAIL ADDRESS: STREET 1: P.O. BOX 675614 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-13 0 0001637715 Reneo Pharmaceuticals, Inc. RPHM 0001780235 O'Donnell Niall C/O RENEO PHARMACEUTICALS, INC. 12230 EL CAMINO REAL, SUITE 230 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2021-04-13 4 C 0 1034600 A 1034600 I By RiverVest Venture Fund IV, L.P. Common Stock 2021-04-13 4 C 0 829113 A 1863713 I By RiverVest Venture Fund IV, L.P. Common Stock 2021-04-13 4 P 0 200000 15.00 A 2063713 I By RiverVest Venture Fund IV, L.P. Series A Preferred Stock 2021-04-13 4 C 0 4629630 0.00 D Common Stock 1034600 0 I By RiverVest Venture Fund IV, L.P. Series B Preferred Stock 2021-04-13 4 C 0 3710116 0.00 D Common Stock 829113 0 I By RiverVest Venture Fund IV, L.P. All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date. The shares held by RiverVest Venture Fund IV, L.P. ("RiverVest Fund IV") are indirectly held by RiverVest Venture Partners IV, L.P., its general partner ("RiverVest Partners IV"). RiverVest Venture Partners IV, LLC is the general partner of RiverVest Partners IV. The individual managers of RiverVest Ventures Partners IV, LLC are Jay Schmelter, John P. McKearn, Ph.D. and the Reporting Person. RiverVest Partners IV, RiverVest Venture Partners IV, LLC and each of the individual managers (including the Reporting Person) share voting and dispositive power with regard to the Company's securities directly held by RiverVest Fund IV. The shares were purchased in the Issuer's initial public offering. /s/ Vineet R. Jindal, Attorney-in-Fact 2021-04-15